HOPE Trials by Quincy Bioscience
Trials
A Randomized, Double-blind, Placebo Controlled Quality of Life Study of the Effect of Apoaequorin Dietary Supplement, on Quality of Life Measures and Aging Expectations in Participants with Multiple Sclerosis.
Efficacy of Apoaequorin for Improving Quality of Life (QOL) Symptoms for Pain and Frequency of Migraine Headache sufferers.
Enrolling
Current HOPE Trials
MS HOPE Continuation Trial is NOW enrolling!
Only Previous MS HOPE Trial participants qualify.- Online Migraine Trial is NOW enrolling.
Recent News
Quincy Bioscience Puts Hope in Walk for Multiple Sclerosis
Quincy Bioscience Sponsors Multiple Sclerosis (MS) Scholarship Program
Quincy Bioscience Announces Launch of MS HOPE Trial
Quincy Bioscience Launches HOPETrials.com; Research Studies More Accessible For Participants
Quincy Bioscience Sponsors Walk for Multiple Sclerosis
Stay Connected
Register to be notified for future HOPE Trials studies
